Conditions: Sarcoma, Soft Tissue
Keywords: metastatic soft-tissue sarcoma pazopanib Soft Tissue Sarcoma placebo
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 369
Healthy volunteers: no

Brief summary:
A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy

Detailed description:

Arms:
arm 1: matching placebo 800 mg once daily orally arm 2: 800 mg once daily orally

Interventions: intervention 1: PAZOPANIB intervention 2: Placebo
Intervention descriptions: intervention 1: 800 mg once daily orally intervention 2: matching placebo 800 mg once daily orally

Protocol document: